We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter reviews an important mediator and its associated factors, the Toll-like receptors (TLRs). It examines the possible role that TLRs serve in neuroimmune interactions within both the central and peripheral nervous systems. The chapter focuses on Toll-like receptor 4 (TLR4) as this TLR appears to contribute directly to neurological pathologies such as neuropathic pain and opioid-induced hyperalgesia, as well as epilepsy. Inflammation in the absence of infection contributes to both injury and disease processes in the nervous system. There are many similarities between the mediators and changes in synaptic connectivity between neuropathic pain and epilepsy. Epileptic seizure conditions are routinely characterized as a neurocentric disease due in large part to the abnormally excessive or synchronous neuronal activity in the brain. The opioid family of drugs, though potent analgesics, are known to be only partially effective in treating neuropathic pain due in large part to the myriad of side effects.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.